Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Atricure News

    23,39 $ -0,36% -0,085 $
    In : 21,989 € | 18.04.24 21:59:59 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A0ES9W
    ISIN: US04963C2098
    US-Symbol: ATRC
    Typ: Aktie

    Atricure News

    18.04.24 - Businesswire
    AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
    AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-​operative pain ...
    10.04.24 - Businesswire
    AtriCure to Announce First Quarter 2024 Financial Results
    AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-​operative pain ...
    26.03.24 - Businesswire
    AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-​operative pain ...
    15.02.24 - Businesswire
    AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
    AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-​operative pain ...
    25.01.24 - Businesswire
    AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference
    AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-​operative pain ...
    24.07.18 - PR Newswire
    ViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a Member of the Board of Directors
    ViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a ...
    03.08.12 - Aktiencheck
    AtriCure-Aktie: "market perform" - JMP Securities
    Die Analysten von JMP Securities stufen die AtriCure-​Aktie von "market outperform" auf "market perform" herab. (Analyse vom 03.08.2012) (03.08.2012/ac/a/a)

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »